INO vs NUE · $88.0M cap vs P/E 25, rev $19.89B
Inovio Pharmaceuticals Inc (INO) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
INO currently screens at market cap $88.0M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the INO and NUE stock pages for the full models.
Not investment advice.